Biospecimen DonationNCT06876857
University of Central Florida CereBank
An observational study of Biospecimen Donation and Brain Injury, run by University of Central Florida at 1 site in United States.
Trial summary
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Biospecimen Donation, Brain Injury, Brain Diseases
- How many people
- 50,000 participants
- Where
- 1 siteUnited States
- Study dates
- 25 Feb 2025to 25 Feb 2075
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: Participants will donate brain tissue for research and education, aimed at improving the diagnosis and treatment of brain diseases.
Who may be able to join
- Be 18 years or older.
- Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.
Who cannot join
- minors (under age 18).
- prisoners.
- pregnant women.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Central Florida
Orlando, Florida, 32827
Britney-Ann Wray, BS, CTBS, CCRP, 4072668742, britney-ann.wray@ucf.edu
Amoy Fraser, PhD, CCRP, PMP, 4072668742, amoy.fraser@ucf.edu
About this study
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Read the detailed description
The purpose of the University of Central CereBank is to be a brain repository to support the research of the faculty of the University of Central Florida College of Medicine. These research studies aim at improving the diagnosis and treatment of brain diseases, such as dementia, to advance medicine. The donated brains will be used for research and educational purposes.
- Conditions
- Biospecimen Donation, Brain Injury, Brain Diseases
- Keywords
- donate, biobank, brain, biospecimen, Alzheimer's Disease, Autism, Huntington's Disease
- Medical subject headings
- Brain Injuries, Brain Diseases, Alzheimer Disease, Autistic Disorder, Huntington Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Donated brain tissue and biospecimens | Persons with brain disease and/ or brain trauma to be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Receipt of donated brain tissue and biospecimens for research and educational purposes
The UCF CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma.
Measured: 75 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2025
- Study start25 Feb 2025
- Primary completion25 Feb 2075 (estimated)
- Study completion25 Feb 2075 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Biospecimen DonationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 50,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Central Florida
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06876857
- Sponsor's protocol ID
- STUDY00007544
- Status last verified
- Mar 2025
- First submitted
- 10 Mar 2025
- Last updated
- 14 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- University of Central Florida CereBank
- ClinicalTrials.gov ID
- NCT06876857
- Acronym / sponsor ID
- STUDY00007544
- Conditions
- Biospecimen Donation, Brain Injury, Brain Diseases
- Keywords
- donate, biobank, brain, biospecimen, Alzheimer's Disease, Autism, Huntington's Disease
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50,000 participants (estimated)
- Lead sponsor
- University of Central FloridaUniversity, hospital or other
- Study start
- 25 Feb 2025 (actual)
- Primary completion
- 25 Feb 2075 (estimated)
- Study completion
- 25 Feb 2075 (estimated)
- First posted
- 14 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Detailed description
The purpose of the University of Central CereBank is to be a brain repository to support the research of the faculty of the University of Central Florida College of Medicine. These research studies aim at improving the diagnosis and treatment of brain diseases, such as dementia, to advance medicine. The donated brains will be used for research and educational purposes.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Donated brain tissue and biospecimens | – | –Persons with brain disease and/ or brain trauma to be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Participants will donate brain tissue for research and education, aimed at improving the diagnosis and treatment of brain diseases.
Key inclusion criteria (2 listed)
- Be 18 years or older.
- Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.
Key exclusion criteria (3 listed)
- minors (under age 18).
- prisoners.
- pregnant women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Receipt of donated brain tissue and biospecimens for research and educational purposes
Time frame: 75 years
The UCF CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2025.
Related trials for Biospecimen Donation
Enrolling by invitationObservational study
Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development
Healthy Volunteers, Syphilis Serologic Assay Development
RecruitingObservational study
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm
RecruitingObservational study
University of Central Florida BEEAST
Biospecimen Donation, Environmental Impact
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Biospecimen Donation and Brain Injury, run by University of Central Florida at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Britney-Ann Wray, BS, CTBS, CCRP (14072668742, britney-ann.wray@ucf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Receipt of donated brain tissue and biospecimens for research and educational purposes (time frame: 75 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2025.